Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 1
2021 3
2022 3
2023 3
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Ogbu EA, Brunner HI, Eloseily E, Aviel YB, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Wahezi DM, Tarvin SE, Sproles A, Chen C, Ruperto N, Huang B, Grom A, Thornton S; Investigators of the PRINTO and PRCSG Networks. Ogbu EA, et al. Among authors: aviel yb. Arthritis Care Res (Hoboken). 2024 Dec;76(12):1723-1732. doi: 10.1002/acr.25417. Epub 2024 Sep 17. Arthritis Care Res (Hoboken). 2024. PMID: 39135452 Free PMC article.
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.
Brunner HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, Alexeeva E, Appenzeller S, Chasnyk V, Griffin T, Suarez CN, Knupp-Oliveira S, Zeft A, Aviel YB, De Ranieri D, Gottlieb BS, Levy DM, Rabinovich CE, Silva CA, Spivakovsky Y, Uziel Y, Ringold S, Xu XL, Leu JH, Lam E, Wang Y, Lovell DJ, Martini A, Ruperto N; Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO). Brunner HI, et al. Among authors: aviel yb. J Rheumatol. 2024 Nov 1;51(11):1125-1134. doi: 10.3899/jrheum.2024-0298. J Rheumatol. 2024. PMID: 39089836 Free article. Clinical Trial.
Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4-11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter study.
Eviatar T, Ziv A, Oved A, Miller-Barmak A, Pappo A, Livny R, Amarilyo G, Aviel YB, Naor R, Pel S, Furer V, Elkayam O, Uziel Y, Heshin-Bekenstein M. Eviatar T, et al. Among authors: aviel yb. Vaccine. 2024 Dec 2;42(26):126426. doi: 10.1016/j.vaccine.2024.126426. Epub 2024 Oct 17. Vaccine. 2024. PMID: 39423454
Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort.
Bustaffa M, Koné-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R, Carrabba M, Aviel YB, Cantarini L, Alessio M, Anton J, Obici L, Gok F, Batu ED, Moreno E, Brogan P, Trachana M, Simonini G, Rigante D, Uziel Y, Insalaco A, Maggio MC, Ruperto N, Gattorno M, Semerano LR. Bustaffa M, et al. Among authors: aviel yb. Semin Arthritis Rheum. 2023 Feb;58:152123. doi: 10.1016/j.semarthrit.2022.152123. Epub 2022 Nov 18. Semin Arthritis Rheum. 2023. PMID: 36404149 No abstract available.
The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort.
Bustaffa M, Koné-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R, Carrabba M, Aviel YB, Cantarini L, Alessio M, Anton J, Obici L, Gok F, Batu ED, Moreno E, Brogan P, Trachana M, Simonini G, Rigante D, Uziel Y, Insalaco A, Maggio MC, Ruperto N, Gattorno M, Semerano LR. Bustaffa M, et al. Among authors: aviel yb. Semin Arthritis Rheum. 2022 Feb;52:151957. doi: 10.1016/j.semarthrit.2022.151957. Epub 2022 Jan 10. Semin Arthritis Rheum. 2022. PMID: 35042149
17 results